The global regulatory direction for nutraceuticals is clear: prove it clinically, or lose the claim.
The problem: clinical trials in the US and EU are expensive enough that the ROI is genuinely difficult.
The solution more international nutraceutical companies are finding: conduct the study in India.
#Nutraceuticals #ClinicalTrials #India #CRO #FDA #EMA #DietarySupplements #EvidenceBased
https://genelifecr.blogspot.com/2026/05/the-evidence-gap-in-nutraceuticals-why.html






